# Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

> **NCT00061984** · PHASE3 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 455 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **BIOLOGICAL:** pegfilgrastim
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** ifosfamide
- **PROCEDURE:** multimodality therapy

## Key facts

- **NCT ID:** NCT00061984
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2010-05
- **Final completion:** 2012-07
- **Target enrollment:** 455 (ACTUAL)
- **Last updated:** 2014-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00061984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00061984, "Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00061984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*